The Bronchiectasis Severity Index. An International Derivation and Validation Study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Bronchiectasis Severity Index. An International Derivation and Validation Study
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 189, Issue 5, Pages 576-585
Publisher
American Thoracic Society
Online
2014-03-02
DOI
10.1164/rccm.201309-1575oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non–Cystic Fibrosis Bronchiectasis
- (2013) Pamela J. McShane et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis
- (2013) David J. Serisier et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis
- (2013) Josje Altenburg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies
- (2013) S. Schembri et al. BMJ-British Medical Journal
- Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study
- (2013) James D Chalmers et al. Lancet Respiratory Medicine
- Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases
- (2013) David J Serisier Lancet Respiratory Medicine
- Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis
- (2012) James D. Chalmers et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification
- (2012) Peter Lange et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Azithromycin in bronchiectasis: when should it be used?
- (2012) Robert Wilson et al. LANCET
- Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
- (2012) Conroy Wong et al. LANCET
- Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis
- (2012) James D. Chalmers et al. MOLECULAR IMMUNOLOGY
- Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients
- (2012) Pieter Goeminne et al. RESPIRATORY RESEARCH
- Research priorities in bronchiectasis
- (2012) Anthony De Soyza et al. THORAX
- Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis
- (2012) James D Chalmers et al. THORAX
- Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis
- (2011) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Fatigue in bronchiectasis
- (2011) K. L. M. Hester et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis
- (2010) Maeve P. Murray et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- British Thoracic Society guideline for non-CFbronchiectasis
- (2010) M. C. Pasteur et al. THORAX
- Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis
- (2010) J. D. Chalmers et al. THORAX
- Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
- (2009) M. R. Loebinger et al. EUROPEAN RESPIRATORY JOURNAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started